UX003 Recombinant Human Beta-glucuronidase
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UX003 Recombinant Human Beta-glucuronidase, covering 2018-01-05 to 2018-01-05. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label Phase 1/2 Study to Assess the Safety, Efficacy and Dose of Study Drug UX003 Recombinant Human Beta-glucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7) [Phase 1, Phase 2]